- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
CMS Administrator Marilyn Tavenner resigns
CMS Administrator Marilyn Tavenner, a life-long public health advocate tapped to lead the $820 billion federal agency, will step down from her role at the end of February.
The Centers for Medicare and Medicaid Services Administrator Marilyn Tavenner will step down from her role at the end of February.
Tavenner, a life-long public health advocate, managed the $820 billion federal agency, which ensures healthcare coverage for 100 million Americans, with 10 regional offices and more than 4,000 employees nationwide.
With the passage of the Affordable Care Act (ACA) in March of 2010, Tavenner also managed CMS as it implements the insurance reforms and affordable insurance exchanges included in the health reform law.
“[Marilyn] Tavenner had become lightening rod for the problems of the ACA and has become the latest official to depart in the ongoing reorganization of the CMS,” said John Santilli partner, Access Market Intelligence, in Trumbull, Conn. “[She] never recovered from the dreadful rollout of Healthcare.gov,” Santilli says.
“By her own admission, Tavenner was sometimes overwhelmed by the politics of the position, and did not participate in the largest issues and decisions of the Obama administration, such as the delay of a requirement for larger employers to offer health coverage to employees.”
According to Santilli, health insurers may not necessarily be pleased to see Tavenner depart, as she did oversee the enrollment of millions of Americans to receive insurance over the last year. “Many of the nation’s leading insurers such as WellPoint [Anthem], Aetna, UnitedHealth Group and Humana, have experienced increasing enrollment of new privately insured members and Medicaid enrollees thanks to the ACA,” Santilli observes.
Principal deputy administrator Andy Slavitt, who helped fix healthcare.gov, will become acting administrator and may be best positioned to take over on permanent basis, according to Santilli.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
